Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Plos One
|
April 1, 2016
The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study
S D Stoker, R Fles, C Herdini, et al.
Breast (Edinburgh, Scotland)
|
November 14, 2024
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
M C Van Maaren, T A Hueting, D J P van Uden, et al.
Breast Cancer Research and Treatment
|
April 25, 2014
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
C A Drukker, M V Nijenhuis, J M Bueno-de-Mesquita, et al.
Familial Cancer
|
February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
M R Wevers, M K Schmidt, E G Engelhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2014
Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature
C A Drukker, H C van den Hout, G S Sonke, et al.
Breast (Edinburgh, Scotland)
|
December 14, 2025
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients
J Meijer, H J G D van den Bongard, L B Koppert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P M L H Vencken, W Reitsma, M Kriege, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Plos One
|
March 31, 2016
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice
S Rebers, E Vermeulen, A P Brandenburg, et al.
British Journal of Cancer
|
August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
G C Wishart, C D Bajdik, E Dicks, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Plos One
|
April 1, 2016
The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study
S D Stoker, R Fles, C Herdini, et al.
Breast (Edinburgh, Scotland)
|
November 14, 2024
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
M C Van Maaren, T A Hueting, D J P van Uden, et al.
Breast Cancer Research and Treatment
|
April 25, 2014
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
C A Drukker, M V Nijenhuis, J M Bueno-de-Mesquita, et al.
Familial Cancer
|
February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
M R Wevers, M K Schmidt, E G Engelhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2014
Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature
C A Drukker, H C van den Hout, G S Sonke, et al.
Breast (Edinburgh, Scotland)
|
December 14, 2025
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients
J Meijer, H J G D van den Bongard, L B Koppert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P M L H Vencken, W Reitsma, M Kriege, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Plos One
|
March 31, 2016
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice
S Rebers, E Vermeulen, A P Brandenburg, et al.
British Journal of Cancer
|
August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
G C Wishart, C D Bajdik, E Dicks, et al.
Page
of 5